Emil Durukan

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 18

Top Topics

Neuropathic Pain

Radical Prostatectomy

Patient Satisfaction

Pulmonary Hypertension

Top Venues

International journal of impotence research

International journal of molecular sciences

Prostate cancer and prostatic diseases

Medicina (Kaunas, Lithuania)

This page only lists publications with an associated author ORCID identifier.

Publications

Emil Durukan, Rune Kraglund, Shad Azad Rashid, Tine Thorkilgaard, Christian Fuglesang Skjødt Jensen, Mikkel Mejlgaard Fode
Phosphodiesterase type 5 inhibitors do not prevent curvature progression but shorten pain duration in the active phase of Peyronie's Disease: A retrospective cohort study. International journal of impotence research 36 (2) (2024)
Ugo Giovanni Falagario, Federico Piramide, Karl H Pang, Emil Durukan, Lazaros Tzelves, Anna Ricapito, Loic Baekelandt, Enrico Checcucci, Diego M Carrion, Carlo Bettocchi, Francesco Esperto
Techniques for Penile Augmentation Surgery: A Systematic Review of Surgical Outcomes, Complications, and Quality of Life. Medicina (Kaunas, Lithuania) 60 (5) (2024)
Emil Durukan, Christian Fuglesang Skjødt Jensen, Mikkel Fode
Response to: "Commentary on: phosphodiesterase type 5 inhibitors do not prevent curvature progression but shorten pain duration in the active phase of Peyronie's disease: a retrospective cohort study". International journal of impotence research 36 (3) (2024)
Emil Durukan, Rune Kraglund, Shad Azad Rashid, Tine Thorkilgaard, Christian Fuglesang Skjødt Jensen, Mikkel Mejlgaard Fode
Phosphodiesterase type 5 inhibitors do not prevent curvature progression but shorten pain duration in the active phase of Peyronie's Disease: A retrospective cohort study. International journal of impotence research 36 (2) (2024)
Emil Durukan, Rune Kraglund, Shad Azad Rashid, Tine Thorkilgaard, Christian Fuglesang Skjødt Jensen, Mikkel Mejlgaard Fode
Phosphodiesterase type 5 inhibitors do not prevent curvature progression but shorten pain duration in the active phase of Peyronie's Disease: A retrospective cohort study. International journal of impotence research (2024)
Giorgio Ivan Russo, Emil Durukan, Maria Giovanna Asmundo, Arturo Lo Giudice, Serena Salzano, Sebastiano Cimino, Antonio Rescifina, Mikkel Fode, Ali Saber Abdelhameed, Rosario Caltabiano, Giuseppe Broggi
CYP7B1 as a Biomarker for Prostate Cancer Risk and Progression: Metabolic and Oncogenic Signatures (Diagnostic Immunohistochemistry Analysis by Tissue Microarray in Prostate Cancer Patients-Diamond Study). International journal of molecular sciences 25 (9) (2024)
Emil Durukan, Rune Kraglund, Shad Azad Rashid, Tine Thorkilgaard, Christian Fuglesang Skjødt Jensen, Mikkel Mejlgaard Fode
Phosphodiesterase type 5 inhibitors do not prevent curvature progression but shorten pain duration in the active phase of Peyronie's Disease: A retrospective cohort study. International journal of impotence research 36 (2) (2024)
Ugo Giovanni Falagario, Federico Piramide, Karl H Pang, Emil Durukan, Lazaros Tzelves, Anna Ricapito, Loic Baekelandt, Enrico Checcucci, Diego M Carrion, Carlo Bettocchi, Francesco Esperto
Techniques for Penile Augmentation Surgery: A Systematic Review of Surgical Outcomes, Complications, and Quality of Life. Medicina (Kaunas, Lithuania) 60 (5) (2024)
Emil Durukan, Rune Kraglund, Shad Azad Rashid, Tine Thorkilgaard, Christian Fuglesang Skjødt Jensen, Mikkel Mejlgaard Fode
Phosphodiesterase type 5 inhibitors do not prevent curvature progression but shorten pain duration in the active phase of Peyronie's Disease: A retrospective cohort study. International journal of impotence research 36 (2) (2024)
Giorgio Ivan Russo, Emil Durukan, Maria Giovanna Asmundo, Arturo Lo Giudice, Serena Salzano, Sebastiano Cimino, Antonio Rescifina, Mikkel Fode, Ali Saber Abdelhameed, Rosario Caltabiano, Giuseppe Broggi
CYP7B1 as a Biomarker for Prostate Cancer Risk and Progression: Metabolic and Oncogenic Signatures (Diagnostic Immunohistochemistry Analysis by Tissue Microarray in Prostate Cancer Patients-Diamond Study). International journal of molecular sciences 25 (9) (2024)
Emil Durukan, Rune Kraglund, Shad Azad Rashid, Tine Thorkilgaard, Christian Fuglesang Skjødt Jensen, Mikkel Mejlgaard Fode
Phosphodiesterase type 5 inhibitors do not prevent curvature progression but shorten pain duration in the active phase of Peyronie's Disease: A retrospective cohort study. International journal of impotence research (2024)
Emil Durukan, Rune Kraglund, Shad Azad Rashid, Tine Thorkilgaard, Christian Fuglesang Skjødt Jensen, Mikkel Mejlgaard Fode
Phosphodiesterase type 5 inhibitors do not prevent curvature progression but shorten pain duration in the active phase of Peyronie's Disease: A retrospective cohort study. International journal of impotence research 36 (2) (2024)
Emil Durukan, Christian Fuglesang Skjødt Jensen, Mikkel Fode
Response to: "Commentary on: phosphodiesterase type 5 inhibitors do not prevent curvature progression but shorten pain duration in the active phase of Peyronie's disease: a retrospective cohort study". International journal of impotence research 36 (3) (2024)
Giorgio Ivan Russo, Emil Durukan, Maria Giovanna Asmundo, Arturo Lo Giudice, Serena Salzano, Sebastiano Cimino, Antonio Rescifina, Mikkel Fode, Ali Saber Abdelhameed, Rosario Caltabiano, Giuseppe Broggi
CYP7B1 as a Biomarker for Prostate Cancer Risk and Progression: Metabolic and Oncogenic Signatures (Diagnostic Immunohistochemistry Analysis by Tissue Microarray in Prostate Cancer Patients-Diamond Study). International journal of molecular sciences 25 (9) (2024)
Emil Durukan, Christian Fuglesang Skjødt Jensen, Mikkel Fode
Response to: "Commentary on: phosphodiesterase type 5 inhibitors do not prevent curvature progression but shorten pain duration in the active phase of Peyronie's disease: a retrospective cohort study". International journal of impotence research (2024)
Emil Durukan, Rune Kraglund, Shad Azad Rashid, Tine Thorkilgaard, Christian Fuglesang Skjødt Jensen, Mikkel Mejlgaard Fode
Phosphodiesterase type 5 inhibitors do not prevent curvature progression but shorten pain duration in the active phase of Peyronie's Disease: A retrospective cohort study. International journal of impotence research 36 (2) (2024)
Andrea Cocci, Marta Pezzoli, Mattia Lo Re, Giorgio Ivan Russo, Maria Giovanna Asmundo, Mikkel Mejlgaard Fode, Giovanni Cacciamani, Sebastiano Cimino, Andrea Minervini, Emil Durukan
Quality of information and appropriateness of ChatGPT outputs for urology patients. Prostate cancer and prostatic diseases (2023)
Andrea Cocci, Marta Pezzoli, Mattia Lo Re, Giorgio Ivan Russo, Maria Giovanna Asmundo, Mikkel Fode, Giovanni Cacciamani, Sebastiano Cimino, Andrea Minervini, Emil Durukan
Quality of information and appropriateness of ChatGPT outputs for urology patients. Prostate cancer and prostatic diseases (2023)